对比增强的T2加权STIR成像对 pituitary腺瘤的成像
Ian T Mark1, Dominik Nickel2, Peter Kollasch2
1From the Mayo Clinic, Department of Radiology (I.T.M., G.B., P.J.F., A.M., S.A.M.), Siemens Medical Solutions USA (P.K., K.D.), Rochester, MN and Siemens Healthineers AG (D.N.), Research & Clinical Translation, Magnetic Resonance, Erlangen Germany. Mark.Ian@mayo.edu.
AJNR. American journal of neuroradiology
|February 20, 2026
概括
这项研究引入了修改的T2加权STIR序列,以更好地检测垂体腺瘤. 该技术通过使正常的垂体组织在MRI扫描上显得更暗来提高瘤的可见性.
科学领域:
- 放射学 放射学是一门学科.
- 医疗成像医学成像
- 神经成像是一种神经成像.
背景情况:
- 垂体腺瘤需要准确的可视化来诊断和治疗.
- 标准的对比后MRI测序有时可以掩盖小或微妙的垂体腺瘤.
- 短tau倒置恢复 (STIR) 序列通常用于脂肪抑制,并避免使用对比剂.
研究的目的:
- 提出一种对比后T2加权STIR序列的新应用.
- 为了提高脑垂体腺瘤在MRI上的显著性.
- 为了克服传统的成像技术的局限性,用于垂体病变.
主要方法:
- 在MRI中应用一个对比后T2加权的STIR序列.
- 利用脂肪和加多增强组织的低强度信号.
- 利用该序列来抑制正常增强垂体腺的信号.
主要成果:
- 修改后的STIR序列使正常的垂体腺体变得低强度.
- 垂体腺瘤在抑制的背景下保持高强度.
- 这导致显著改善了腺瘤的可视化和明显性.
结论:
- 后对比T2加权的STIR是一种有价值的技术来检测垂体腺瘤.
- 这种方法提高了脑下垂体神经成像的诊断准确性.
- 这种方法为可视化具有挑战性的垂体腺瘤提供了一个实用的解决方案.
相关概念视频
Magnetic Resonance Imaging
10.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
10.0K
Imaging Studies IV: Magnetic Resonance Imaging
303
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
303


